456 related articles for article (PubMed ID: 33517890)
1. Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson's disease.
Hou YF; Shan C; Zhuang SY; Zhuang QQ; Ghosh A; Zhu KC; Kong XK; Wang SM; Gong YL; Yang YY; Tao B; Sun LH; Zhao HY; Guo XZ; Wang WQ; Ning G; Gu YY; Li ST; Liu JM
Microbiome; 2021 Jan; 9(1):34. PubMed ID: 33517890
[TBL] [Abstract][Full Text] [Related]
2. Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease.
Cui C; Han Y; Li H; Yu H; Zhang B; Li G
Front Cell Infect Microbiol; 2022; 12():887407. PubMed ID: 36034698
[TBL] [Abstract][Full Text] [Related]
3. Polymannuronic acid prevents dopaminergic neuronal loss via brain-gut-microbiota axis in Parkinson's disease model.
Dong XL; Wang X; Liu F; Liu X; Du ZR; Li RW; Xue CH; Wong KH; Wong WT; Zhao Q; Tang QJ
Int J Biol Macromol; 2020 Dec; 164():994-1005. PubMed ID: 32710966
[TBL] [Abstract][Full Text] [Related]
4. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D
Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980
[TBL] [Abstract][Full Text] [Related]
5. EGCG ameliorates neuronal and behavioral defects by remodeling gut microbiota and TotM expression in Drosophila models of Parkinson's disease.
Xu Y; Xie M; Xue J; Xiang L; Li Y; Xiao J; Xiao G; Wang HL
FASEB J; 2020 Apr; 34(4):5931-5950. PubMed ID: 32157731
[TBL] [Abstract][Full Text] [Related]
6. Rubusoside mitigates neuroinflammation and cellular apoptosis in Parkinson's disease, and alters gut microbiota and metabolite composition.
Meng T; Zhang Y; Huang J; Pandey V; Fu S; Ma S
Phytomedicine; 2024 Feb; 124():155309. PubMed ID: 38237261
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
[TBL] [Abstract][Full Text] [Related]
8. Optimization of the Preparation Process of Glucuronomannan Oligosaccharides and Their Effects on the Gut Microbiota in MPTP-Induced PD Model Mice.
Wang B; Geng L; Wang J; Wei Y; Yan C; Wu N; Yue Y; Zhang Q
Mar Drugs; 2024 Apr; 22(5):. PubMed ID: 38786584
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection of chicoric acid in a mouse model of Parkinson's disease involves gut microbiota and TLR4 signaling pathway.
Wang N; Feng BN; Hu B; Cheng YL; Guo YH; Qian H
Food Funct; 2022 Feb; 13(4):2019-2032. PubMed ID: 35103734
[TBL] [Abstract][Full Text] [Related]
10. The gut microbiota metabolite propionate ameliorates intestinal epithelial barrier dysfunction-mediated Parkinson's disease via the AKT signaling pathway.
Huang T; Shi H; Xu Y; Ji L
Neuroreport; 2021 Feb; 32(3):244-251. PubMed ID: 33470765
[TBL] [Abstract][Full Text] [Related]
11. New Avenues for Parkinson's Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota.
Lorente-Picón M; Laguna A
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33804226
[TBL] [Abstract][Full Text] [Related]
12. Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson's disease via gut microbiota-GLP-1 pathway.
Sun J; Li H; Jin Y; Yu J; Mao S; Su KP; Ling Z; Liu J
Brain Behav Immun; 2021 Jan; 91():703-715. PubMed ID: 33148438
[TBL] [Abstract][Full Text] [Related]
13. Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson's disease.
Koutzoumis DN; Vergara M; Pino J; Buddendorff J; Khoshbouei H; Mandel RJ; Torres GE
Exp Neurol; 2020 Mar; 325():113159. PubMed ID: 31843492
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective Effects of Sodium Butyrate by Restoring Gut Microbiota and Inhibiting TLR4 Signaling in Mice with MPTP-Induced Parkinson's Disease.
Guo TT; Zhang Z; Sun Y; Zhu RY; Wang FX; Ma LJ; Jiang L; Liu HD
Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839287
[TBL] [Abstract][Full Text] [Related]
15. Microbiota-mediated effects of Parkinson's disease medications on Parkinsonian non-motor symptoms in male transgenic mice.
Radisavljevic N; Metcalfe-Roach A; Cirstea M; Tabusi MM; Bozorgmehr T; Bar-Yoseph H; Finlay BB
mSphere; 2024 Jan; 9(1):e0037923. PubMed ID: 38078745
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota-induced CXCL1 elevation triggers early neuroinflammation in the substantia nigra of Parkinsonian mice.
Ma XZ; Chen LL; Qu L; Li H; Wang J; Song N; Xie JX
Acta Pharmacol Sin; 2024 Jan; 45(1):52-65. PubMed ID: 37674043
[TBL] [Abstract][Full Text] [Related]
17. Electroacupuncture may alleviate behavioral defects via modulation of gut microbiota in a mouse model of Parkinson's disease.
Han QQ; Fu Y; Le JM; Pilot A; Cheng S; Chen PQ; Wu H; Wan GQ; Gu XF
Acupunct Med; 2021 Oct; 39(5):501-511. PubMed ID: 33557583
[TBL] [Abstract][Full Text] [Related]
18. The link between the gut microbiota and Parkinson's Disease: A systematic mechanism review with focus on α-synuclein transport.
Nielsen SD; Pearson NM; Seidler K
Brain Res; 2021 Oct; 1769():147609. PubMed ID: 34371014
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective Effects of
Lee YZ; Cheng SH; Chang MY; Lin YF; Wu CC; Tsai YC
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047769
[TBL] [Abstract][Full Text] [Related]
20. Gut brain axis: an insight into microbiota role in Parkinson's disease.
Moustafa SA; Mohamed S; Dawood A; Azar J; Elmorsy E; Rizk NAM; Salama M
Metab Brain Dis; 2021 Oct; 36(7):1545-1557. PubMed ID: 34370175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
